Genentech’s Dr. Charles Fuchs: “The Era of Personalized Cancer Care is Here” - Stand Up To Cancer

News

Genentech’s Dr. Charles Fuchs: “The Era of Personalized Cancer Care is Here”

Genentech, a leader in biomarker-based oncology therapies, presented new data from 19 approved and investigational medicine across 20 cancer types this year at the ASCO Annual Meeting, advancing its mission to bring innovative personalized therapies to patients from all backgrounds.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.